newsfilter
← Latest News
GlobeNewswire·

Calidi Biotherapeutics Announces $1.2 Million Registered Direct Offering

SAN DIEGO, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE:CLDI) ("Calidi" or the "Company"), a biotechnology company pioneering the development of targeted genetic medicines,